相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy
Christopher P. Fox et al.
BLOOD (2010)
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation
Kenneth P. Micklethwaite et al.
BLOOD (2010)
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
J. Joseph Melenhorst et al.
BLOOD (2010)
Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders
Kimberley Jones et al.
BLOOD (2010)
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
Andreas Moosmann et al.
BLOOD (2010)
Allo-HLA reactivity of virus-specific memory T cells is common
Avital L. Amir et al.
BLOOD (2010)
Adoptive T cell therapy of cancer
Malcolm K. Brenner et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders
Anna Merlo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Virus-Specific Cytotoxic CD4+ T Cells for the Treatment of EBV-Related Tumors
Anna Merlo et al.
JOURNAL OF IMMUNOLOGY (2010)
Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
Chrystal U. Louis et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Allogeneic T-Cell Therapy for Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease: Long-Term Follow-Up
Tanzina Haque et al.
TRANSPLANTATION (2010)
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients
Chrystal U. Louis et al.
BLOOD (2009)
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes
Shin Kaneko et al.
BLOOD (2009)
Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells
Jihene Klibi et al.
BLOOD (2009)
Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease
Jennifer Brewin et al.
BLOOD (2009)
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)
Biagio De Angelis et al.
BLOOD (2009)
CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells
Heather M. Long et al.
BLOOD (2009)
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
Ann M. Leen et al.
BLOOD (2009)
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
Patrick J. Hanley et al.
BLOOD (2009)
Adoptive immunotherapy of cancer using CD4+ T cells
Pawel Muranski et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Cytolytic mechanisms and T-cell receptor Vβ usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes
Victoria J. Vanhoutte et al.
IMMUNOLOGY (2009)
Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-γ T cell responses
Ann M. Moormann et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Epitope Specificity and Clonality of EBV-Specific CTLs Used to Treat Posttransplant Lymphoproliferative Disease
Karen A. McAulay et al.
JOURNAL OF IMMUNOLOGY (2009)
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
Christian S. Hinrichs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2008)
T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant
P. Comoli et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells
Hiroya Kobayashi et al.
CANCER RESEARCH (2008)
Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
Ayako Demachi-Okamura et al.
CANCER SCIENCE (2008)
Patients with Epstein Barr virus-positive lymphomas have decreased CD4+ T-cell responses to the viral nuclear antigen 1
Kevin N. Heller et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Epstein-Barr virus sustains tumor killers
Richard J. O'Reilly
NATURE MEDICINE (2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products
Maaike E. Ressing et al.
SEMINARS IN CANCER BIOLOGY (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
Jiang Li et al.
PLOS ONE (2007)
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
Catherine M. Bollard et al.
BLOOD (2007)
Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma
Maher K. Gandhi et al.
BLOOD (2007)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
The AP1-dependent secretion of galectin-1 by Reed - Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Przemyslaw Juszczynski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+T Cell Preparations for Therapy
Dinesh Adhikary et al.
PLOS ONE (2007)
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
P. Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma
Neil A. Marshall et al.
EXPERIMENTAL HEMATOLOGY (2007)
Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants
Richard J. O'Reilly et al.
IMMUNOLOGIC RESEARCH (2007)
Treatment of solid organ transplant recipients with autologolus Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)
Barbara Savoldo et al.
BLOOD (2006)
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
Ann M. Leen et al.
NATURE MEDICINE (2006)
EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses
Elise Landais et al.
JOURNAL OF IMMUNOLOGY (2006)
In vivo expansion of LMP 1-and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation
Catherine M. Bollard et al.
LEUKEMIA & LYMPHOMA (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
D Adhikary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Epstein-Barr virus, cytokines, and inflammation: A cocktail. for the pathogenesis of Hodgkin's lymphoma?
G Khan
EXPERIMENTAL HEMATOLOGY (2006)
Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas
HI Cho et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes
P Comoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Treatment of Epstein-Barr-virus-associated primary CNS B-cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation
RF Wynn et al.
LANCET ONCOLOGY (2005)
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes
KCM Straathof et al.
BLOOD (2005)
Adoptive immunotherapy for EBV-associated malignancies
S Gottschalk et al.
LEUKEMIA & LYMPHOMA (2005)
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes
KS Voo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells
HJ Wagner et al.
CANCER GENE THERAPY (2004)
Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes
S Pakakasama et al.
TRANSPLANTATION (2004)
Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells
J Mautner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Cytotoxic T lymphocyte therapy for Epstein-Barr virus Hodgkin's disease
CM Bollard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of Epstein-Barr virus-associated diseases
GM Wilkie et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
JC Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma
P Comoli et al.
ANNALS OF ONCOLOGY (2004)
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1
J Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Prompt versus preemptive intervention for EBV lymphoproliferative disease
HJ Wagner et al.
BLOOD (2004)
Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease
KG Lucas et al.
CANCER (2004)
Clinical effects of infusing Anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection
M Hagihara et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy
MA Sherritt et al.
TRANSPLANTATION (2003)
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection
B Savoldo et al.
BLOOD (2002)
Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma
Q Sun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
CM Bollard et al.
BLOOD (2002)
Infusion of autologous Epstein-Barr virus (EBV) -: specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
P Comoli et al.
BLOOD (2002)
Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma
D Chua et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
Correction of DiGeorge anomaly with EBV-induced lymphoma by transplantation of organ-cultured thymus and Epstein-Barr-specific cytotoxic T lymphocytes
R Hong et al.
CLINICAL IMMUNOLOGY (2001)
分享论文
